{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:50:44Z","timestamp":1791319844635,"version":"4.3.1"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2508705"],"award-info":[{"award-number":["2023YFC2508705"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jneuroim.2026.579007","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T16:19:52Z","timestamp":1781885992000},"page":"579007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinical characteristics of IgG4-related hypertrophic pachymeningitis with and without serum ANCA positivity"],"prefix":"10.1016","volume":"419","author":[{"given":"Qingqing","family":"Zhuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingzi","family":"Zhangbao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingshi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiting","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2026.579007_bb0005","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/mrcr\/rxac025","article-title":"Refractory IgG4-related disease complicated with organising pneumonia and hypertrophic pachymeningitis","volume":"6","author":"Abe","year":"2022","journal-title":"Mod. Rheumatol. Case Rep."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0010","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2926419","article-title":"Hypertrophic pachymeningitis in Chinese patients: presentation, radiological findings, and clinical course","volume":"2020","author":"Bi","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0015","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1097\/PAS.0b013e3181abdfc2","article-title":"IgG4-related sclerosing pachymeningitis: a previously unrecognized form of central nervous system involvement in IgG4-related sclerosing disease","volume":"33","author":"Chan","year":"2009","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0020","first-page":"1","article-title":"IgG4-related hypertrophic pachymeningitis with cerebral venous thrombosis","volume":"82","author":"Coelho","year":"2024","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0025","doi-asserted-by":"crossref","DOI":"10.1111\/1756-185X.15410","article-title":"A case report: hypertrophic pachymeningitis and IgG4-related disease","volume":"27","author":"da Silva","year":"2024","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0030","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jneuroim.2013.10.008","article-title":"Diagnostic value of IgG4 indices in IgG4-related hypertrophic pachymeningitis","volume":"266","author":"Della-Torre","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0035","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/jnnp-2017-316519","article-title":"Intrathecal rituximab for IgG(4)-related hypertrophic pachymeningitis","volume":"89","author":"Della-Torre","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2026.579007_bb0040","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s12026-021-09215-2","article-title":"Immunoglobulin G4-related disease: case report and literature review","volume":"69","author":"Dong","year":"2021","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0045","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1007\/s00701-022-05340-5","article-title":"IgG4-related hypertrophic pachymeningitis with tumor-like intracranial and intracerebral lesions","volume":"164","author":"Esmaeilzadeh","year":"2022","journal-title":"Acta Neurochir."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103285","article-title":"Pachymeningitis associated with IgG4-related disease and ANCA positivity: case report and review of the literature","volume":"22","author":"Gautier","year":"2023","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0055","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/art.41982","article-title":"2022 American College of Rheumatology\/European Alliance of associations for rheumatology classification criteria for eosinophilic granulomatosis with Polyangiitis","volume":"74","author":"Grayson","year":"2022","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0060","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.6324","article-title":"IgG4-related disease associated with the primary manifestation of recurrent cerebral venous thrombosis: a rare case report","volume":"10","author":"Haj Mohamad Ebrahim Ketabforoush","year":"2022","journal-title":"Clin. Case Reports"},{"key":"10.1016\/j.jneuroim.2026.579007_bb0065","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jbspin.2015.07.016","article-title":"IgG4-related disease presenting as hypertrophic pachymeningitis and compressive optic neuropathy","volume":"83","author":"Hwang","year":"2016","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jneuroim.2026.579007_bb0070","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s13760-016-0680-8","article-title":"Isolated IgG4-related hypertrophic pachymeningitis","volume":"117","author":"Ioannidis","year":"2017","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0075","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kez009","article-title":"Glossopharyngeal\/vagus nerve disorder due to IgG4-related hypertrophic pachymeningitis","author":"Kosumi","year":"2019","journal-title":"Rheumatology (Oxford, England)."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0080","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4103\/sni.sni_231_18","article-title":"Severe headache in a patient with meningioma showing extensive dural tail correlates with IgG4-positive plasma cells and eosinophils: a case report and review of literature","volume":"9","author":"Kuranari","year":"2018","journal-title":"Surg. Neurol. Int."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0085","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1111\/1756-185X.14680","article-title":"MPO-ANCA-positive granulomatosis with polyangiitis and concurrent IgG4-related disease with periaortitis and tubulointerstitial nephritis: a case report of a new overlap syndrome?","volume":"26","author":"Kuske","year":"2023","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/S2665-9913(23)00299-0","article-title":"Fibrotic phenotype of IgG4-related disease","volume":"6","author":"Lanzillotta","year":"2024","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0095","doi-asserted-by":"crossref","first-page":"87","DOI":"10.14791\/btrt.2014.2.2.87","article-title":"Immunoglobulin G4-related hypertrophic pachymeningitis with skull involvement","volume":"2","author":"Lee","year":"2014","journal-title":"Brain Tumor Res. Treat."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0100","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000568","article-title":"Immunoglobulin G4-related hypertrophic pachymeningitis: a case-oriented review","volume":"6","author":"Levraut","year":"2019","journal-title":"Neurol. Neuroimmunol. Neuroinflam."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0105","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.1007\/s10072-025-08337-x","article-title":"NeuroImages: IgG4-related disease with meningeal and parenchymal involvement on MRI and histopathology","volume":"46","author":"Li","year":"2025","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.wneu.2015.03.035","article-title":"IgG4-related hypertrophic pachymeningitis at the Falx Cerebrii with brain parenchymal invasion: a case report","volume":"84","author":"Li","year":"2015","journal-title":"World Neurosurg."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0115","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000041","article-title":"Refractory IgG4-related intracranial hypertrophic pachymeningitis responded to rituximab","volume":"1","author":"Liao","year":"2014","journal-title":"Neurol. Neuroimmunol. Neuroinflam."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0120","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/pn-2023-003750","article-title":"IgG4-related hypertrophic pachymeningitis with chronic subdural haematoma","volume":"23","author":"Lichtblau","year":"2023","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0125","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jamaneurol.2014.243","article-title":"IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment","volume":"71","author":"Lu","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0130","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/practneurol-2017-001826","article-title":"Rituximab for corticosteroid-resistant relapsing IgG4-related intracranial pachymeningitis: report of two cases","volume":"18","author":"Mageau","year":"2018","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0135","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1093\/rheumatology\/keab124","article-title":"What is the meaning of ANCA positivity in IgG4-related disease?","volume":"60","author":"Martin-Nares","year":"2021","journal-title":"Rheumatology (Oxford, England)"},{"key":"10.1016\/j.jneuroim.2026.579007_bb0140","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000341","article-title":"IgG4-related hypertrophic pachymeningitis coexpressing antineutrophil cytoplasmic antibodies","volume":"4","author":"Massey","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflam."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0145","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.2169\/internalmedicine.8550-21","article-title":"Hypertrophic pachymeningitis with characteristics of both IgG4-related disorders and granulomatosis with polyangiitis","volume":"61","author":"Mori","year":"2022","journal-title":"Int. Med. (Tokyo, Japan)."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0150","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1016\/j.neuchi.2022.02.007","article-title":"Chiari decompression for syringomyelia in the setting of IgG4-related hypertrophic pachymeningitis: a case-based update","volume":"68","author":"Moskalik","year":"2022","journal-title":"Neuro-Chirurgie."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2026.1776836","article-title":"IgG4-related hypertrophic pachymeningitis presenting with marked dural thickening, widespread white matter changes, and rectus gyrus transdiaphragmatic herniation into the sella turcica: a case report","volume":"17","author":"Ogawa","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0160","doi-asserted-by":"crossref","first-page":"606","DOI":"10.2169\/internalmedicine.5780-25","article-title":"Development of nephritis and abnormal lung shadow in a patient with IgG4-related hypertrophic pachymeningitis with MPO-ANCA positivity after unplanned interruption of maintenance glucocorticoid therapy","volume":"65","author":"Origuchi","year":"2026","journal-title":"Int. Med. (Tokyo, Japan)."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0165","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12883-020-01815-z","article-title":"Polycystic subdural hygroma associated with immunoglobulin G4-related intracranial hypertrophic pachymeningitis: a case report","volume":"20","author":"Ota","year":"2020","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0170","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jocn.2014.12.020","article-title":"Immunoglobulin-G4-related hypertrophic pachymeningitis with antineutrophil cytoplasmatic antibodies effectively treated with rituximab","volume":"22","author":"Popkirov","year":"2015","journal-title":"J. Clini. Neurosci."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0175","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3389\/fneur.2014.00192","article-title":"Bilateral vision loss secondary to Pachymeningitis in a patient with IgG4-related disease","volume":"5","author":"Ramirez","year":"2014","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0180","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/art.41986","article-title":"2022 American College of Rheumatology\/European Alliance of associations for rheumatology classification criteria for granulomatosis with Polyangiitis","volume":"74","author":"Robson","year":"2022","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117420","article-title":"The neurology of IGG4-related disease","volume":"424","author":"Saitakis","year":"2021","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0190","article-title":"IgG4-related disease presenting as hypertrophic Pachymeningitis","volume":"14","author":"Sapkota","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.jneuroim.2026.579007_bb0195","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000197","article-title":"The severe side of the IgG4-related hypertrophic pachymeningitis disease spectrum","volume":"3","author":"Schubert","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflam."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0200","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/ccr3.3855","article-title":"Successful treatment of IgG4-related hypertrophic pachymeningitis with induction rituximab and dexamethasone followed by maintenance rituximab","volume":"9","author":"Seegobin","year":"2021","journal-title":"Clin. Case Reports"},{"key":"10.1016\/j.jneuroim.2026.579007_bb0205","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.reuma.2022.11.006","article-title":"Hypertrophic pachymeningitis due to IgG4-related disease (RD-IgG4). A case report","volume":"19","author":"Sergio","year":"2023","journal-title":"Reumatol. Clin."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103338","article-title":"Hypertrophic pachymeningitis in ANCA-associated vasculitis: clinical and immunopathological features and insights","volume":"22","author":"Shimojima","year":"2023","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0215","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4103\/aian.AIAN_283_18","article-title":"A series of biopsy-proven patients with immunoglobulin G4-related neurological disease","volume":"22","author":"Sireesha","year":"2019","journal-title":"Ann. Indian Acad. Neurol."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2019.576997","article-title":"Intrathecal rituximab in immunoglobulin G4-hypertrophic pachymeningitis","volume":"334","author":"Soares","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0225","article-title":"IgG4-related hypertrophic pachymeningitis with serum ANCA positivity","author":"Suda","year":"2024","journal-title":"Int. Med. (Tokyo, Japan)."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0230","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2169\/internalmedicine.3511-24","article-title":"IgG4-related hypertrophic pachymeningitis with serum ANCA positivity","volume":"64","author":"Suda","year":"2025","journal-title":"Int. Med. (Tokyo, Japan)."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0235","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/art.41983","article-title":"2022 American College of Rheumatology\/European Alliance of associations for rheumatology classification criteria for microscopic Polyangiitis","volume":"74","author":"Suppiah","year":"2022","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0240","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/14397595.2020.1859710","article-title":"The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD","volume":"31","author":"Umehara","year":"2021","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0245","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.5470","article-title":"The great imposter: a case report of IgG4-RD hypertrophic pachymeningitis with skull lytic lesion and pulmonary nodules","volume":"10","author":"Wadiwala","year":"2022","journal-title":"Clin. Case Reports"},{"key":"10.1016\/j.jneuroim.2026.579007_bb0250","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/RHU.0000000000000488","article-title":"Metachronous involvement, diagnostic imprecision of serum immunoglobulin G4 levels, and discordance between clinical and radiological findings in immunoglobulin G4-related pachymeningitis: a longitudinal case report","volume":"23","author":"Waheed","year":"2017","journal-title":"J. Clin. Rheumatol."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0255","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.41120","article-title":"The 2019 American College of Rheumatology\/European league against rheumatism classification criteria for IgG4-related disease","volume":"72","author":"Wallace","year":"2020","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0260","article-title":"Recurrent cerebral venous thrombosis associated with IgG4-related hypertrophic pachymeningitis: case report and literature review","author":"Wang","year":"2026","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0265","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/practneurol-2015-001275","article-title":"IgG4-related disease: a rare but treatable cause of refractory intracranial hypertension","volume":"16","author":"Williams","year":"2016","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0270","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s41016-021-00233-5","article-title":"The protean manifestations of central nervous system IgG4-related hypertrophic pachymeningitis: a report of two cases","volume":"7","author":"Woo","year":"2021","journal-title":"Chin. Neurosurg. J."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0275","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000502569","article-title":"A case of hypertrophic pachymeningitis associated with immunoglobulin-G4 and c-ANCA","volume":"11","author":"Wyrostek","year":"2019","journal-title":"Case Rep. Neurol."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0280","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s13760-021-01667-5","article-title":"Treatment-responsive case of focal clivus IgG4-related hypertrophic pachymeningitis mimicking meningioma; case report","volume":"121","author":"Yamamuro","year":"2021","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0285","article-title":"Cerebral venous sinus thrombosis complicating IgG4-related hypertrophic pachymeningitis","author":"Yang","year":"2025","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0290","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4078\/jrd.2023.0023","article-title":"Immunoglobulin G4-related hypertrophic pachymeningitis with an isolated scalp mass mimicking a brain tumor: a case report and literature review","volume":"31","author":"Yeo","year":"2024","journal-title":"J. Rheumatic Dis."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0295","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3988\/jcn.2022.18.4.481","article-title":"Hypertrophic pachymeningitis and interstitial lung disease in IgG4-related disease","volume":"18","author":"Yim","year":"2022","journal-title":"J. Clini. Neurol. (Seoul, Korea)"},{"key":"10.1016\/j.jneuroim.2026.579007_bb0300","first-page":"699","article-title":"IgG4-related hypertrophic pachymeningitis: a case report","volume":"56","author":"Yin","year":"2023","journal-title":"Chin. J. Neurol."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0305","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/brain\/awt314","article-title":"Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody","volume":"137","author":"Yokoseki","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2026.579007_bb0310","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1136\/jnnp-2013-306410","article-title":"A nationwide survey of hypertrophic pachymeningitis in Japan","volume":"85","author":"Yonekawa","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2026.579007_bb0315","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s10067-018-4402-x","article-title":"No overlap between IgG4-related disease and microscopic polyangiitis and granulomatosis with polyangiitis despite elevated serum IgG4 at diagnosis: a retrospective monocentric study","volume":"38","author":"Yoo","year":"2019","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0320","doi-asserted-by":"crossref","first-page":"S571","DOI":"10.1097\/RHU.0000000000000989","article-title":"A rare case of IgG4-related disease presenting as a unilateral severe dacryoadenitis complicated by hypophysitis and hypertrophic pachymeningitis","volume":"27","author":"Yoshida","year":"2021","journal-title":"J. Clin. Rheumatol."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0325","doi-asserted-by":"crossref","first-page":"6269","DOI":"10.12998\/wjcc.v10.i18.6269","article-title":"Clivus-involved immunoglobulin G4 related hypertrophic pachymeningitis mimicking meningioma: a case report","volume":"10","author":"Yu","year":"2022","journal-title":"World J. Clin. Cases"},{"key":"10.1016\/j.jneuroim.2026.579007_bb0330","first-page":"268","article-title":"Anti-neutrophil cytoplasmic antibody-associated vasculitis overlap immunoglobulin G4-related disease: a 4 case series and review of literature","volume":"24","author":"Zhang","year":"2020","journal-title":"China J. Rheumatol."},{"key":"10.1016\/j.jneuroim.2026.579007_bb0335","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.21037\/apm-19-452","article-title":"Imaging features, clinicopathological analysis and diagnostic strategy of IgG4-related hypertrophic pachymeningitis","volume":"9","author":"Zhao","year":"2020","journal-title":"Ann. Palliat. Med."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826001566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826001566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:58:19Z","timestamp":1791316699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572826001566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":67,"alternative-id":["S0165572826001566"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.579007","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics of IgG4-related hypertrophic pachymeningitis with and without serum ANCA positivity","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.579007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"579007"}}